In this issue:
- MRI cutoff for radiographic part of modified New York criteria in axial SpA
- JAK inhibitors in Behçet syndrome
- PREVENT for predicting CV disease event risk in RA
- Upadacitinib vs. adalimumab for RA after TNF inhibitor failure/intolerance
- Early GI manifestations in systemic sclerosis
- Refining serological scores in RA classification
- Pregnancy outcomes in axial SpA
- Joint tenderness/pain and ultrasound abnormalities in anti-CCP+ individuals at risk of RA
- Optimising use of PROMs in axial SpA
- Predictors of relapse, early escalation and 1 year of glucocorticoid use in new-onset PMR
Please login below to download this issue (PDF)